These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 16233888)

  • 1. 1H MRS studies in the Finnish boron neutron capture therapy project: detection of 10B-carrier, L-p-boronophenylalanine-fructose.
    Timonen M; Kankaanranta L; Lundbom N; Collan J; Kangasmäki A; Kortesniemi M; Häkkinen AM; Lönngren A; Karjalainen S; Rasilainen M; Leinonen J; Huitti T; Jääskeläinen J; Kouri M; Savolainen S; Heikkinen S
    Eur J Radiol; 2005 Nov; 56(2):154-9. PubMed ID: 16233888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-nuclear MRS and 19F MRI of 19F-labelled and 10B-enriched p-boronophenylalanine-fructose complex to optimize boron neutron capture therapy: phantom studies at high magnetic fields.
    Porcari P; Capuani S; Campanella R; La Bella A; Migneco LM; Maraviglia B
    Phys Med Biol; 2006 Jun; 51(12):3141-54. PubMed ID: 16757868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo (19)F MRI and (19)F MRS of (19)F-labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT).
    Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Campanella R; Migneco LM; Pastore FS; Maraviglia B
    Phys Med Biol; 2008 Dec; 53(23):6979-89. PubMed ID: 19001698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T2 corrected quantification method of L-p-boronophenylalanine using proton magnetic resonance spectroscopy for boron neutron capture therapy.
    Yamamoto Y; Isobe T; Yamamoto T; Shibata Y; Anno I; Nakai K; Shirakawa M; Matsushita A; Sato E; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S345-7. PubMed ID: 19406648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy.
    Zuo CS; Prasad PV; Busse P; Tang L; Zamenhof RG
    Med Phys; 1999 Jul; 26(7):1230-6. PubMed ID: 10435522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 10B-editing 1H-detection and 19F MRI strategies to optimize boron neutron capture therapy.
    Capuani S; Porcari P; Fasano F; Campanella R; Maraviglia B
    Magn Reson Imaging; 2008 Sep; 26(7):987-93. PubMed ID: 18486394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquisition-weighted MRSI for detection and quantification of BNCT 10B-carrier L-p-boronophenylalanine-fructose complex, a phantom study.
    Timonen M; Kankaanranta L; Lundbom N; Kortesniemi M; Seppälä T; Kouri M; Savolainen S; Heikkinen S
    J Radiat Res; 2009 Sep; 50(5):435-40. PubMed ID: 19584572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer.
    Kankaanranta L; Seppälä T; Koivunoro H; Saarilahti K; Atula T; Collan J; Salli E; Kortesniemi M; Uusi-Simola J; Mäkitie A; Seppänen M; Minn H; Kotiluoto P; Auterinen I; Savolainen S; Kouri M; Joensuu H
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):475-82. PubMed ID: 17689034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
    H-Stenstam B
    Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284
    [No Abstract]   [Full Text] [Related]  

  • 11. Biodistribution studies of boronophenylalanine-fructose in melanoma and brain tumor patients in Argentina.
    Liberman SJ; Dagrosa A; Jiménez Rebagliati RA; Bonomi MR; Roth BM; Turjanski L; Castiglia SI; González SJ; Menéndez PR; Cabrini R; Roberti MJ; Batistoni DA
    Appl Radiat Isot; 2004 Nov; 61(5):1095-100. PubMed ID: 15308198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam.
    Kiger WS; Lu XQ; Harling OK; Riley KJ; Binns PJ; Kaplan J; Patel H; Zamenhof RG; Shibata Y; Kaplan ID; Busse PM; Palmer MR
    Appl Radiat Isot; 2004 Nov; 61(5):1075-81. PubMed ID: 15308195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
    Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boron Neutron Capture Therapy for glioblastoma multiforme: advantage of prolonged infusion of BPA-f.
    Sköld K; H-Stenstam B; Diaz AZ; Giusti V; Pellettieri L; Hopewell JW
    Acta Neurol Scand; 2010 Jul; 122(1):58-62. PubMed ID: 19951268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo 19F MR imaging and spectroscopy for the BNCT optimization.
    Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Migneco LM; Campanella R; Maraviglia B; Pastore FS
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S365-8. PubMed ID: 19375924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study.
    Kankaanranta L; Seppälä T; Koivunoro H; Välimäki P; Beule A; Collan J; Kortesniemi M; Uusi-Simola J; Kotiluoto P; Auterinen I; Serèn T; Paetau A; Saarilahti K; Savolainen S; Joensuu H
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):369-76. PubMed ID: 21236605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1H MRS of a boron neutron capture therapy 10B-carrier, L-p-boronophenylalanine-fructose complex, BPA-F: phantom studies at 1.5 and 3.0 T.
    Heikkinen S; Kangasmäki A; Timonen M; Kankaanranta L; Häkkinen AM; Lundbom N; Vähätalo J; Savolainen S
    Phys Med Biol; 2003 Apr; 48(8):1027-39. PubMed ID: 12741499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ion microscopy imaging of 10B from p-boronophenylalanine in a brain tumor model for boron neutron capture therapy.
    Smith DR; Chandra S; Coderre JA; Morrison GH
    Cancer Res; 1996 Oct; 56(19):4302-6. PubMed ID: 8813111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.
    Coderre JA; Chanana AD; Joel DD; Elowitz EH; Micca PL; Nawrocky MM; Chadha M; Gebbers JO; Shady M; Peress NS; Slatkin DN
    Radiat Res; 1998 Feb; 149(2):163-70. PubMed ID: 9457896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
    Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
    J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.